Effect of conjunction matrigel with MFP implantation on the tumorigenesis, proliferation, apoptosis and metastasis of breast cancer cells with different expression of Her2
- VernacularTitle:Matrigel对不同Her2表达的乳腺癌细胞原位成瘤、增殖、凋亡和转移的影响
- Author:
Yandan YAO
;
Songyin HUANG
;
Guangqing YUAN
;
Fengyan YU
;
Chang GONG
;
Weijuan JIA
;
Wei WU
;
Erwei SONG
;
Fengxi SU
- Publication Type:Journal Article
- Keywords:
Matrigel;
Breast neoplasms;
Genes,Her2;
Cell proliferation;
Apoptosis
- From:
Chinese Journal of Pathophysiology
2009;25(12):2338-2343
- CountryChina
- Language:Chinese
-
Abstract:
AIM: To detect the effect of conjunction matrigel with mammary fad pat(MFP)implantation on the tumorigenesis, proliferation, apoptosis and metastasis of Her2 positive and negative breast cancer model. METHODS: The Her2 positive BT 474 and Her2 negative MDA-MB 231 breast cancer cells were injected into MFP of nude mice with or without matrigel to establish breast cancer model. The tumor volume was measured every 3 d. Followed up for 30 d after implantation, the nude mice were killed and the tumors and associated organs were dissected for pathological sectioning and staining with hematoxylin and eosin. The time of tumor formation and the tumorigenesis were determined after implantation. The tumor volume and metastasis rate were calculated and compared with each other. The proliferation and apoptosis of Her2 positive and negative tumors were also determined. RESULTS: Matrigel and MFP implantation technology shortened the time of tumorigenesis significantly(P<0.01). The tumorigenesis rate of BT 474 and MDA-MB 231 breast cancer cells did not show any different(P>0.05). The metastasis rate of MDA-MB 231 breast cancer cells were improved from 25.0% to 37.5%(P<0.05). CONCLUSION: Matrigel and MFP implantation can be combined to shorten the time of tumor formation by two kinds of breast cancer cells, and improve the metastasis of Her2 negative MDA-MB 231 cells. Using matrigel does not show any effect of proliferation and apoptosis on Her2 positive and negative breast cancer cells.
